Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients
To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution. We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC...
Gespeichert in:
Veröffentlicht in: | PloS one 2016-05, Vol.11 (5), p.e0154578-e0154578 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0154578 |
---|---|
container_issue | 5 |
container_start_page | e0154578 |
container_title | PloS one |
container_volume | 11 |
creator | Wang, Baojun Gong, Huijie Zhang, Xu Li, Hongzhao Ma, Xin Song, Erlin Gao, Jiangping Dong, Jun |
description | To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution.
We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC who underwent retroperitoneoscopic treatment at the General Hospital of People's Liberation Army from 2008 to 2014. The estimated glomerular filtration rate was calculated and compared among different surgical procedures. The overall survival and recurrence free survival were assessed based on information from recent follow-up.
Fifty-six patients underwent bilateral retroperitoneoscopic surgeries in staged procedures, and four patients underwent bilateral retroperitoneoscopic surgeries in simultaneous procedures. Among the former group of patients, 34 underwent bilateral partial nephrectomy, 12 underwent radical nephrectomy followed by partial nephrectomy, and 10 underwent partial nephrectomy followed by radical nephrectomy. Bilateral partial nephrectomy can better preserve renal function (p = 0.040) and the sequence of partial nephrectomy and radical nephrectomy did not affect functional outcomes (p = 0.790). One patient undergoing simultaneous procedures developed acute renal failure and required temporary hemodialysis. At 3 and 5 years, overall survival rates were 93.0% and 89.4%, and recurrence free survival rates were 90.5% and 81.6%. High nuclear grade (p = 0.014) was related to disease recurrence.
Staged bilateral partial nephrectomy was efficient in preserving renal function. The survival of patients with bilateral synchronous sporadic renal tumors was similar to that of patients with unilateral nonmetastatic tumors. Nuclear grade was an independent prognostic factor of disease recurrence. |
doi_str_mv | 10.1371/journal.pone.0154578 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1786123698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A453420261</galeid><doaj_id>oai_doaj_org_article_aad03d21ec644add90cf09da868c0933</doaj_id><sourcerecordid>A453420261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-ef86f770bb57050d1fe5e7034df4e5f553c6f3fd9cff4b7179da00f6fd7d59a03</originalsourceid><addsrcrecordid>eNqNk12L1DAUhoso7rr6D0QLgujFjEnTJK0Xwjr4MbAwsqPehkw-ZrJ0mm6Sinvhf_fMTHeZyl5IoQ0nz3lPz3s4WfYcoykmHL-78n1oZTPtfGumCNOS8upBdoprUkxYgcjDo_NJ9iTGK4QoqRh7nJ0UHBOGa3ya_fnoGplMkE2-vGnVJvjW9zFfdj5I7VR-aaBGPjMNvGRQrvVb-R6iKfjOBJeguI_Kd4AuUwCltTMxl63O5y3Ibo12EMwXfVJ-Czfe5gzl32Rypk3xafbIyiaaZ8P3LPvx-dP32dfJxeLLfHZ-MVGsLtLE2IpZztFqRTmiSGNrqOGIlNqWhlpKiWKWWF0ra8sVx7zWEiHLrOaa1hKRs-zlQbdrfBSDc1FgXjFcEFZXQMwPhPbySnTBbWW4EV46sQ_4sBYyJKcaI6TUiOgCG8XKUmpdI2URVKxYpVBNCGh9GKr1KzBAQafg70h0fNO6jVj7X6KsaFHVGATeDALBX_cmJrF1UcEMJLjd7_-bo7rgbIe--ge9v7uBWktowLXWQ121ExXnJSVlgYq91vQeCh5ttk7BpK2D-Cjh7SgBmGR-p7XsYxTz5eX_s4ufY_b1Ebsxskmb6Js-Od_GMVgeQBV8jMHYO5MxErstuXVD7LZEDFsCaS-OB3SXdLsW5C-DfQ7j</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786123698</pqid></control><display><type>article</type><title>Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients</title><source>MEDLINE</source><source>Public Library of Science</source><source>Full-Text Journals in Chemistry (Open access)</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Wang, Baojun ; Gong, Huijie ; Zhang, Xu ; Li, Hongzhao ; Ma, Xin ; Song, Erlin ; Gao, Jiangping ; Dong, Jun</creator><creatorcontrib>Wang, Baojun ; Gong, Huijie ; Zhang, Xu ; Li, Hongzhao ; Ma, Xin ; Song, Erlin ; Gao, Jiangping ; Dong, Jun</creatorcontrib><description>To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution.
We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC who underwent retroperitoneoscopic treatment at the General Hospital of People's Liberation Army from 2008 to 2014. The estimated glomerular filtration rate was calculated and compared among different surgical procedures. The overall survival and recurrence free survival were assessed based on information from recent follow-up.
Fifty-six patients underwent bilateral retroperitoneoscopic surgeries in staged procedures, and four patients underwent bilateral retroperitoneoscopic surgeries in simultaneous procedures. Among the former group of patients, 34 underwent bilateral partial nephrectomy, 12 underwent radical nephrectomy followed by partial nephrectomy, and 10 underwent partial nephrectomy followed by radical nephrectomy. Bilateral partial nephrectomy can better preserve renal function (p = 0.040) and the sequence of partial nephrectomy and radical nephrectomy did not affect functional outcomes (p = 0.790). One patient undergoing simultaneous procedures developed acute renal failure and required temporary hemodialysis. At 3 and 5 years, overall survival rates were 93.0% and 89.4%, and recurrence free survival rates were 90.5% and 81.6%. High nuclear grade (p = 0.014) was related to disease recurrence.
Staged bilateral partial nephrectomy was efficient in preserving renal function. The survival of patients with bilateral synchronous sporadic renal tumors was similar to that of patients with unilateral nonmetastatic tumors. Nuclear grade was an independent prognostic factor of disease recurrence.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0154578</identifier><identifier>PMID: 27136191</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Accounting ; Accuracy ; Adrenalectomy ; Adult ; Aged ; Biology and Life Sciences ; Biopsy ; Carcinoma, Renal Cell - mortality ; Carcinoma, Renal Cell - surgery ; Carcinoma, Renal Cell - therapy ; Care and treatment ; Clinical medicine ; Dialysis ; Disease-Free Survival ; Female ; Glomerular filtration rate ; Hemodialysis ; Hospitals ; Humans ; Kidney - pathology ; Kidney - surgery ; Kidney cancer ; Kidney diseases ; Kidney Neoplasms - mortality ; Kidney Neoplasms - surgery ; Kidney Neoplasms - therapy ; Laparoscopy ; Male ; Medical prognosis ; Medicine and Health Sciences ; Middle Aged ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - surgery ; Neoplasm Recurrence, Local - therapy ; Neoplasm Staging ; Nephrectomy ; Patient outcomes ; Patients ; Quality ; Renal cell carcinoma ; Renal failure ; Renal function ; Retrospective Studies ; Risk factors ; Surgeons ; Surgery ; Survival ; Survival Rate ; Treatment Outcome ; Tumors ; Urology</subject><ispartof>PloS one, 2016-05, Vol.11 (5), p.e0154578-e0154578</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Wang et al 2016 Wang et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-ef86f770bb57050d1fe5e7034df4e5f553c6f3fd9cff4b7179da00f6fd7d59a03</citedby><cites>FETCH-LOGICAL-c692t-ef86f770bb57050d1fe5e7034df4e5f553c6f3fd9cff4b7179da00f6fd7d59a03</cites><orcidid>0000-0002-0608-6509</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852891/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852891/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27136191$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Baojun</creatorcontrib><creatorcontrib>Gong, Huijie</creatorcontrib><creatorcontrib>Zhang, Xu</creatorcontrib><creatorcontrib>Li, Hongzhao</creatorcontrib><creatorcontrib>Ma, Xin</creatorcontrib><creatorcontrib>Song, Erlin</creatorcontrib><creatorcontrib>Gao, Jiangping</creatorcontrib><creatorcontrib>Dong, Jun</creatorcontrib><title>Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution.
We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC who underwent retroperitoneoscopic treatment at the General Hospital of People's Liberation Army from 2008 to 2014. The estimated glomerular filtration rate was calculated and compared among different surgical procedures. The overall survival and recurrence free survival were assessed based on information from recent follow-up.
Fifty-six patients underwent bilateral retroperitoneoscopic surgeries in staged procedures, and four patients underwent bilateral retroperitoneoscopic surgeries in simultaneous procedures. Among the former group of patients, 34 underwent bilateral partial nephrectomy, 12 underwent radical nephrectomy followed by partial nephrectomy, and 10 underwent partial nephrectomy followed by radical nephrectomy. Bilateral partial nephrectomy can better preserve renal function (p = 0.040) and the sequence of partial nephrectomy and radical nephrectomy did not affect functional outcomes (p = 0.790). One patient undergoing simultaneous procedures developed acute renal failure and required temporary hemodialysis. At 3 and 5 years, overall survival rates were 93.0% and 89.4%, and recurrence free survival rates were 90.5% and 81.6%. High nuclear grade (p = 0.014) was related to disease recurrence.
Staged bilateral partial nephrectomy was efficient in preserving renal function. The survival of patients with bilateral synchronous sporadic renal tumors was similar to that of patients with unilateral nonmetastatic tumors. Nuclear grade was an independent prognostic factor of disease recurrence.</description><subject>Accounting</subject><subject>Accuracy</subject><subject>Adrenalectomy</subject><subject>Adult</subject><subject>Aged</subject><subject>Biology and Life Sciences</subject><subject>Biopsy</subject><subject>Carcinoma, Renal Cell - mortality</subject><subject>Carcinoma, Renal Cell - surgery</subject><subject>Carcinoma, Renal Cell - therapy</subject><subject>Care and treatment</subject><subject>Clinical medicine</subject><subject>Dialysis</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Glomerular filtration rate</subject><subject>Hemodialysis</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Kidney - pathology</subject><subject>Kidney - surgery</subject><subject>Kidney cancer</subject><subject>Kidney diseases</subject><subject>Kidney Neoplasms - mortality</subject><subject>Kidney Neoplasms - surgery</subject><subject>Kidney Neoplasms - therapy</subject><subject>Laparoscopy</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Neoplasm Staging</subject><subject>Nephrectomy</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Quality</subject><subject>Renal cell carcinoma</subject><subject>Renal failure</subject><subject>Renal function</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Survival</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Urology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk12L1DAUhoso7rr6D0QLgujFjEnTJK0Xwjr4MbAwsqPehkw-ZrJ0mm6Sinvhf_fMTHeZyl5IoQ0nz3lPz3s4WfYcoykmHL-78n1oZTPtfGumCNOS8upBdoprUkxYgcjDo_NJ9iTGK4QoqRh7nJ0UHBOGa3ya_fnoGplMkE2-vGnVJvjW9zFfdj5I7VR-aaBGPjMNvGRQrvVb-R6iKfjOBJeguI_Kd4AuUwCltTMxl63O5y3Ibo12EMwXfVJ-Czfe5gzl32Rypk3xafbIyiaaZ8P3LPvx-dP32dfJxeLLfHZ-MVGsLtLE2IpZztFqRTmiSGNrqOGIlNqWhlpKiWKWWF0ra8sVx7zWEiHLrOaa1hKRs-zlQbdrfBSDc1FgXjFcEFZXQMwPhPbySnTBbWW4EV46sQ_4sBYyJKcaI6TUiOgCG8XKUmpdI2URVKxYpVBNCGh9GKr1KzBAQafg70h0fNO6jVj7X6KsaFHVGATeDALBX_cmJrF1UcEMJLjd7_-bo7rgbIe--ge9v7uBWktowLXWQ121ExXnJSVlgYq91vQeCh5ttk7BpK2D-Cjh7SgBmGR-p7XsYxTz5eX_s4ufY_b1Ebsxskmb6Js-Od_GMVgeQBV8jMHYO5MxErstuXVD7LZEDFsCaS-OB3SXdLsW5C-DfQ7j</recordid><startdate>20160502</startdate><enddate>20160502</enddate><creator>Wang, Baojun</creator><creator>Gong, Huijie</creator><creator>Zhang, Xu</creator><creator>Li, Hongzhao</creator><creator>Ma, Xin</creator><creator>Song, Erlin</creator><creator>Gao, Jiangping</creator><creator>Dong, Jun</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0608-6509</orcidid></search><sort><creationdate>20160502</creationdate><title>Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients</title><author>Wang, Baojun ; Gong, Huijie ; Zhang, Xu ; Li, Hongzhao ; Ma, Xin ; Song, Erlin ; Gao, Jiangping ; Dong, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-ef86f770bb57050d1fe5e7034df4e5f553c6f3fd9cff4b7179da00f6fd7d59a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Accounting</topic><topic>Accuracy</topic><topic>Adrenalectomy</topic><topic>Adult</topic><topic>Aged</topic><topic>Biology and Life Sciences</topic><topic>Biopsy</topic><topic>Carcinoma, Renal Cell - mortality</topic><topic>Carcinoma, Renal Cell - surgery</topic><topic>Carcinoma, Renal Cell - therapy</topic><topic>Care and treatment</topic><topic>Clinical medicine</topic><topic>Dialysis</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Glomerular filtration rate</topic><topic>Hemodialysis</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Kidney - pathology</topic><topic>Kidney - surgery</topic><topic>Kidney cancer</topic><topic>Kidney diseases</topic><topic>Kidney Neoplasms - mortality</topic><topic>Kidney Neoplasms - surgery</topic><topic>Kidney Neoplasms - therapy</topic><topic>Laparoscopy</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Neoplasm Staging</topic><topic>Nephrectomy</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Quality</topic><topic>Renal cell carcinoma</topic><topic>Renal failure</topic><topic>Renal function</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Survival</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Baojun</creatorcontrib><creatorcontrib>Gong, Huijie</creatorcontrib><creatorcontrib>Zhang, Xu</creatorcontrib><creatorcontrib>Li, Hongzhao</creatorcontrib><creatorcontrib>Ma, Xin</creatorcontrib><creatorcontrib>Song, Erlin</creatorcontrib><creatorcontrib>Gao, Jiangping</creatorcontrib><creatorcontrib>Dong, Jun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints Resource Center</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Baojun</au><au>Gong, Huijie</au><au>Zhang, Xu</au><au>Li, Hongzhao</au><au>Ma, Xin</au><au>Song, Erlin</au><au>Gao, Jiangping</au><au>Dong, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-05-02</date><risdate>2016</risdate><volume>11</volume><issue>5</issue><spage>e0154578</spage><epage>e0154578</epage><pages>e0154578-e0154578</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution.
We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC who underwent retroperitoneoscopic treatment at the General Hospital of People's Liberation Army from 2008 to 2014. The estimated glomerular filtration rate was calculated and compared among different surgical procedures. The overall survival and recurrence free survival were assessed based on information from recent follow-up.
Fifty-six patients underwent bilateral retroperitoneoscopic surgeries in staged procedures, and four patients underwent bilateral retroperitoneoscopic surgeries in simultaneous procedures. Among the former group of patients, 34 underwent bilateral partial nephrectomy, 12 underwent radical nephrectomy followed by partial nephrectomy, and 10 underwent partial nephrectomy followed by radical nephrectomy. Bilateral partial nephrectomy can better preserve renal function (p = 0.040) and the sequence of partial nephrectomy and radical nephrectomy did not affect functional outcomes (p = 0.790). One patient undergoing simultaneous procedures developed acute renal failure and required temporary hemodialysis. At 3 and 5 years, overall survival rates were 93.0% and 89.4%, and recurrence free survival rates were 90.5% and 81.6%. High nuclear grade (p = 0.014) was related to disease recurrence.
Staged bilateral partial nephrectomy was efficient in preserving renal function. The survival of patients with bilateral synchronous sporadic renal tumors was similar to that of patients with unilateral nonmetastatic tumors. Nuclear grade was an independent prognostic factor of disease recurrence.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27136191</pmid><doi>10.1371/journal.pone.0154578</doi><orcidid>https://orcid.org/0000-0002-0608-6509</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2016-05, Vol.11 (5), p.e0154578-e0154578 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1786123698 |
source | MEDLINE; Public Library of Science; Full-Text Journals in Chemistry (Open access); DOAJ Directory of Open Access Journals; PubMed Central; EZB Electronic Journals Library |
subjects | Accounting Accuracy Adrenalectomy Adult Aged Biology and Life Sciences Biopsy Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - surgery Carcinoma, Renal Cell - therapy Care and treatment Clinical medicine Dialysis Disease-Free Survival Female Glomerular filtration rate Hemodialysis Hospitals Humans Kidney - pathology Kidney - surgery Kidney cancer Kidney diseases Kidney Neoplasms - mortality Kidney Neoplasms - surgery Kidney Neoplasms - therapy Laparoscopy Male Medical prognosis Medicine and Health Sciences Middle Aged Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - surgery Neoplasm Recurrence, Local - therapy Neoplasm Staging Nephrectomy Patient outcomes Patients Quality Renal cell carcinoma Renal failure Renal function Retrospective Studies Risk factors Surgeons Surgery Survival Survival Rate Treatment Outcome Tumors Urology |
title | Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T17%3A16%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bilateral%20Synchronous%20Sporadic%20Renal%20Cell%20Carcinoma:%20Retroperitoneoscopic%20Strategies%20and%20Intermediate%20Outcomes%20of%2060%20Patients&rft.jtitle=PloS%20one&rft.au=Wang,%20Baojun&rft.date=2016-05-02&rft.volume=11&rft.issue=5&rft.spage=e0154578&rft.epage=e0154578&rft.pages=e0154578-e0154578&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0154578&rft_dat=%3Cgale_plos_%3EA453420261%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1786123698&rft_id=info:pmid/27136191&rft_galeid=A453420261&rft_doaj_id=oai_doaj_org_article_aad03d21ec644add90cf09da868c0933&rfr_iscdi=true |